PRI working on spike protein of new Covid variant received from China: Balkrishna   

Thursday, 18 January 2024 | PNS | HARIDWAR

With the spike in the number of the Covid sub-variant JN.1 cases across the country, Acharya Balkrishna said that the Patanjali Research Institute (PRI) has received the spike protein of the JN.1 variant Omicron from Sino Biological Lab based in China for research.  He further said that at a time when the new variant is spreading its tentacles across the country with surging cases, Patanjali could not sit idle and added that PRI has already started working on spike protein in order to find a cure for the variant- triggered virus infection. 

Calling the variant a cause for concern, he said that intense research could help them find something that would arrest the spread of the virus. “We had to work hard for one and half months to collect the spike protein of the variant from China. Now, the scientists working for PRI are happy with its arrival. They have started working on it with full vigour,” Balkrishna said. Speaking on the matter, PRI principal scientist Anurag Varshney said that they will conduct an infection control trial on the spike protein through the use of Coronil.        

Patanjali health centre opens at Lakshmeshwar, Almora

DEHRADUN: Patanjali health centre at Lakshmeshwar in Almora was inaugurated by the State BJP vice-president and former MLA Kailash Sharma on Wednesday. After the inauguration, he had Swadeshi Samriddhi Card made in his name and purchased a number of Patanjali products by availing the discount the card offers. An office-bearer of the health centre said that by availing this card, a customer would get a five to seven per cent discount aside from life insurance worth   Rs 50,000. He further said that people are thronging this centre in large numbers to buy the Patanjali food and herbal products.